Withdrawal of Registration Statement (ammendment) (aw)
21 June 2022 - 8:02PM
Edgar (US Regulatory)
June
17, 2022
VIA
EDGAR
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
| Attention: |
Laura Crotty |
| Phone: |
(202) 394-0334 |
| |
|
| Re: |
RetinalGenix
Technologies Inc. Application for Withdrawal on Form AW |
| |
pursuant
to Rule 477 of the Securities Act of 1933, as amended,
of
Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 |
Ladies
and Gentlemen:
Pursuant
to Rule 477 (a) of the Securities Act of 1933, as amended, RetinalGenix Technologies Inc. (the “Registrant”) hereby respectfully
requests the immediate withdrawal of the Registrant’s Post-Effective Amendment No. 2 to the Registration Statement on Form S-1
(the “Amendment”), filed with the Commission on June 13, 2022.
As
discussed with SEC staff members, the Registrant is requesting the withdrawal of the Amendment because the Amendment references and was
filed under an incorrect File Number, 333-262282. No securities have been sold in connection with
the Amendment.
| |
Very
truly yours, |
| |
RetinalGenix
Technologies Inc. |
| |
|
|
| |
By: |
/s/
Jerry Katzman |
| |
Name:
|
Jerry
Katzman |
| |
Title:
|
President,
Secretary, Treasurer and Director |
| |
|
(Principal
Executive Officer and Principal Financial Officer and Accounting Officer) |
Retinalgenix Technologies (QB) (USOTC:RTGN)
Historical Stock Chart
From May 2024 to Jun 2024
Retinalgenix Technologies (QB) (USOTC:RTGN)
Historical Stock Chart
From Jun 2023 to Jun 2024
